Sage Therapeutics' (SAGE) CEO Jeff Jonas on Q3 2017 Results - Earnings Call Transcript [Seeking Alpha]
Sage Therapeutics, Inc. (SAGE)
Last sage therapeutics, inc. earnings: 2/27 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.sagerx.com/investor-relations
Company Research
Source: Seeking Alpha
Sage Therapeutics (NASDAQ: SAGE ) Q3 2017 Earnings Conference Call November 2, 2017 8:00 a.m. ET Executives Paul Cox - IR Jeff Jonas - CEO Steve Kanes - Chief Medical Officer Kimi Iguchi - CFO Analysts Salveen Richter - Goldman Sachs Tazeen Ahmad - Bank of America Merrill Lynch Laura Chico - Raymond James Ritu Baral - Cowen & Company Cory Kasimov - JPMorgan Brian Abrahams - RBC Capital Markets Danielle Brill - Needham & Company Gary Nachman - BMO Capital Markets Adam Walsh - Stifel Nicolaus Tim Lugo - William Blair Operator Good morning, and welcome to Sage Therapeutics Third Quarter 2017 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors & Media section of Sage's Web site at sagerx.com. This call is the property of Sage Therapeutics and recording, reproduction or transmission of this call without the express written consent of Sage Therapeutics is strictly prohibited. Please note
Show less
Read more
Impact Snapshot
Event Time:
SAGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SAGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SAGE alerts
High impacting Sage Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SAGE
News
- We're Keeping An Eye On Sage Therapeutics' (NASDAQ:SAGE) Cash Burn Rate [Yahoo! Finance]Yahoo! Finance
- Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target raised by analysts at JPMorgan Chase & Co. from $24.00 to $29.00. They now have an "overweight" rating on the stock.MarketBeat
- Why Is Sage Therapeutics, Inc. (SAGE) Down 22% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target raised by analysts at Morgan Stanley from $20.00 to $22.00. They now have an "equal weight" rating on the stock.MarketBeat
- Sage Therapeutics to Present at Upcoming March Investor ConferencesBusiness Wire
SAGE
Earnings
- 2/14/24 - Beat
SAGE
Sec Filings
- 3/27/24 - Form SC
- 3/26/24 - Form 8-K
- 2/21/24 - Form SC
- SAGE's page on the SEC website